Dr. Colvin is subspecialty head of Renal Pathology, and works closely with the diagnostic Immunopathology Unit in Pathology. He is also affiliated with the Kidney/Pancreas/Islet Transplant Programs at the Transplant Center at Mass General Hospital.
Dr. Colvin's principal clinical interest is renal pathology, particularly the immunological aspects of renal disease and transplantation. He is the subspecialty head of the Renal Pathology Diagnostic Service, works closely with the Immunopathology Unit , and is affiliated with the Kidney/Pancreas/Islet Transplant Programs at the Massachusetts General Hospital Transplant Center. He has contributed seminal work in the field of antibody mediated rejection, and approaches to tolerance induction. He is a senior investigator in the Immunopathology Research Laboratory and the Colvin Laboratory, and has been continuously funded by the NIH since 1976. He teaches at Harvard Medical School, has trained over 45 fellows, and lectures widely.
Dr. Colvin contributed seminal work in the field of antibody mediated rejection and approaches to tolerance induction. The C4d assay that is now used in transplant centers worldwide in the diagnosis of antibody-mediated rejection of allografts. He is a principal investigator and head of the Immunopathology Research Laboratory, for translational research in immunology and transplantation, and has been continuously funded by the National Institutes of Health (NIH) since 1976. The Colvin Laboratory focuses on the mechanisms of allograft rejection and acceptance in animal and human studies, as revealed by pathologic, immunopathologic and molecular techniques. Dr. Colvin is affiliated with the Center for Transplantation Sciences (CTS). His other research interests include acute and chronic antibody-mediated rejection, and mechanisms of graft acceptance.